Literature DB >> 27038981

Is Quasi-moyamoya Disease a Uniform Disease Entity? A Three-Dimensional Constructive Interference in Steady State Imaging Study.

Shusuke Yamamoto1, Masaki Koh2, Daina Kashiwazaki2, Naoki Akioka2, Naoya Kuwayama2, Kyo Noguchi3, Satoshi Kuroda2.   

Abstract

BACKGROUND: Quasi-moyamoya disease (MMD) or moyamoya syndrome is based on various underlying diseases and radiologically simulates MMD, but its disease entity is still unclear. Recent studies have proven specific shrinkage of the involved arteries in MMD. Using 3-dimensional constructive interference in steady state (3D-CISS), therefore, this study aimed to analyze the outer diameter of the involved arteries in quasi-MMD.
METHODS: This study included 9 patients with quasi-MMD (unilateral type, n = 2; bilateral type, n = 7). Using 3D-CISS, the outer diameter was quantified in the internal carotid artery distal to the posterior communicating artery (C1), the horizontal portion of the middle and anterior cerebral arteries (M1 and A1, respectively), and the basilar artery. Control values were obtained from 17 healthy subjects.
RESULTS: In 7 of 9 patients, the outer diameters of C1, M1, and A1 were significantly smaller than those of the controls. On the other hand, the values were normal in other 2 patients. There was no significant difference in the underlying disorders between the 2 groups. All 3 pediatric patients are categorized into the arterial shrinkage group, but 2 of 6 adult patients were not.
CONCLUSIONS: These findings strongly suggest that quasi-MMD is not a uniform disease entity and includes at least 2 pathophysiologically different groups: the arterial shrinkage group and the nonarterial shrinkage group. A certain subgroup of MMD patients may be misdiagnosed as quasi-MMD because of the patients' comorbid disorders and mixed up with the patients who present angiographic findings similar to MMD in spite of the lack of arterial shrinkage.
Copyright © 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D-CISS; MRI; diagnosis; outer diameter; quasi-moyamoya disease

Mesh:

Year:  2016        PMID: 27038981     DOI: 10.1016/j.jstrokecerebrovasdis.2016.02.029

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome.

Authors:  Kaijiang Kang; Jingjing Lu; Dong Zhang; Youxiang Li; Dandan Wang; Peng Liu; Bohong Li; Yi Ju; Xingquan Zhao
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

Review 2.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

Review 3.  Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease.

Authors:  Brandon M Fox; Kirsten B Dorschel; Michael T Lawton; John E Wanebo
Journal:  Front Neurol       Date:  2021-09-03       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.